Home Supplements How We Rate Blog
Coleus forskohlii extract (Labdane diterpene)

Forskolin

Research reviewed: Up until 03/2026

Forskolin (Coleus forskohlii extract (Labdane diterpene)) is a dietary supplement with 7 published peer-reviewed studies involving 680 participants, researched for Body Composition, Testosterone Support, Cardiovascular Health and 1 more areas.

7
Studies
680
Participants
1986–2017
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Very Strong Evidence

Body Composition

Moderate
2 studies 1 of 2 positive 53 participants

Testosterone Support

Moderate
1 study 1 of 1 positive 30 participants

Cardiovascular Health

Moderate
2 studies 0 of 2 positive 20 participants 1 human

Intraocular Pressure

Strong
2 studies 2 of 2 positive 116 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

6/7
Randomised
5/7
Double-Blind
4/7
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2005)
30
Study 2 (2005)
23
Study 1 (2007)
30
Study 1 (1986)
20
Study 2 (2009)
0
Study 1 (2014)
50
Study 2 (2017)
66

Research Timeline

When the studies were published

1
1986
2
2005
1
2007
1
2009
1
2014
1
2017

All Studies

Detailed breakdown of each trial. Click to expand.

Body Composition

1

To evaluate Coleus forskohlii (forskolin) supplementation on body composition in overweight men.

2005 30 participants 12 weeks 250 mg/day Coleus forskohlii extract (10% forskolin)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate Coleus forskohlii (forskolin) supplementation on body composition in overweight men.

Dose

250 mg/day Coleus forskohlii extract (10% forskolin)

Participants

30 overweight to obese men

Duration

12 weeks

Results

Forskolin significantly decreased body fat percentage (-4.3% vs +0.1% placebo) and increased lean body mass. Bone density also improved. The cAMP-mediated lipolysis mechanism is proposed as the primary mechanism.

How They Measured It

DXA body composition (fat mass, lean mass), BMI

Read full study
2

To assess Coleus forskohlii supplementation for prevention of weight gain in overweight women.

2005 23 participants 12 weeks 250 mg/day Coleus forskohlii extract (10% forskolin)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess Coleus forskohlii supplementation for prevention of weight gain in overweight women.

Dose

250 mg/day Coleus forskohlii extract (10% forskolin)

Participants

23 overweight women

Duration

12 weeks

Results

Coleus forskohlii prevented weight gain in overweight women and reduced metabolic rate decline associated with hypocaloric dieting. Lipid profiles did not change significantly.

How They Measured It

Body weight, body fat, metabolic rate, lipid panel

Read full study

Testosterone Support

1

To evaluate the effect of forskolin on serum testosterone in men.

2007 30 participants 8 weeks 500 mg/day Coleus forskohlii (10% forskolin)
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate the effect of forskolin on serum testosterone in men.

Dose

500 mg/day Coleus forskohlii (10% forskolin)

Participants

30 healthy men

Duration

8 weeks

Results

Forskolin supplementation significantly increased serum testosterone levels by 33% compared to placebo. LH levels were also elevated, suggesting stimulation of the hypothalamic-pituitary-gonadal axis via cAMP.

How They Measured It

Serum total and free testosterone, LH, FSH

Read full study

Cardiovascular Health

1

To assess forskolin on cardiac function and blood pressure in patients with dilated cardiomyopathy.

1986 20 participants Acute administration Intravenous forskolin at low and high doses
Human Study RCT Mixed

Study Type

Randomised, controlled trial

Purpose

To assess forskolin on cardiac function and blood pressure in patients with dilated cardiomyopathy.

Dose

Intravenous forskolin at low and high doses

Participants

20 patients with dilated cardiomyopathy

Duration

Acute administration

Results

Intravenous forskolin dose-dependently increased cardiac output and LVEF while reducing systemic vascular resistance. The positive inotropic effect via cAMP was confirmed in patients with impaired cardiac function.

How They Measured It

LVEF, stroke volume, systemic vascular resistance, blood pressure

Read full study
2

To investigate the vasodilatory and hypotensive mechanisms of forskolin.

2009 ? participants Acute 1 mg/kg IV forskolin
Animal Study Mixed

Study Type

Animal study

Purpose

To investigate the vasodilatory and hypotensive mechanisms of forskolin.

Dose

1 mg/kg IV forskolin

Participants

Sprague-Dawley rats

Duration

Acute

Results

Forskolin produced dose-dependent vasodilation and blood pressure reduction via adenylate cyclase-stimulated cAMP elevation in vascular smooth muscle. The mechanism is distinct from nitric oxide pathways.

How They Measured It

Vascular tone assays, blood pressure monitoring, cAMP levels in vascular tissue

Read full study

Intraocular Pressure

1

To assess topical and oral forskolin supplementation on intraocular pressure in glaucoma patients.

2014 50 participants 12 months 10 mg oral Coleus forskohlii extract twice daily
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess topical and oral forskolin supplementation on intraocular pressure in glaucoma patients.

Dose

10 mg oral Coleus forskohlii extract twice daily

Participants

50 patients with primary open-angle glaucoma

Duration

12 months

Results

Forskolin supplementation significantly reduced intraocular pressure compared to placebo. As an adjunct to standard glaucoma therapy, it produced additional 10-15% reductions in IOP beyond medication effects.

How They Measured It

Intraocular pressure (Goldmann applanation tonometry)

Read full study
2

To evaluate the effect of combined oral supplements including forskolin on IOP in ocular hypertension.

2017 66 participants 12 months Forskolin 15 mg in combination with other nutrients
Human Study RCT Double-Blind Positive

Study Type

Randomised, double-blind, controlled

Purpose

To evaluate the effect of combined oral supplements including forskolin on IOP in ocular hypertension.

Dose

Forskolin 15 mg in combination with other nutrients

Participants

66 patients with ocular hypertension

Duration

12 months

Results

The forskolin-containing supplement significantly reduced mean IOP by 2.87 mmHg versus control and maintained visual field scores. The combination approach was well tolerated.

How They Measured It

IOP, visual field testing, optic nerve imaging

Read full study

Frequently Asked Questions

Common questions about Forskolin research

What does the research say about Forskolin?

There are currently 8 peer-reviewed studies on Forskolin (Coleus forskohlii extract (Labdane diterpene)), involving 680 total participants. Research covers Body composition, Testosterone support, Cardiovascular health and 1 more areas. The overall evidence strength is rated as Very Strong.

How strong is the evidence for Forskolin?

The evidence is currently rated as "Very Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (6 human studies, 1 animal study), and reported outcomes.

What health goals has Forskolin been studied for?

Forskolin has been researched for: Body composition, Testosterone support, Cardiovascular health, Intraocular pressure. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on Forskolin based on human trials?

Yes, 6 out of 8 studies are human trials. The remaining 1 is an animal study. Human trials carry more weight in our evidence scoring system.